bone marrow-derived mesenchymal stem cells

BIOLOGICAL4 trials

Sponsors

University of California, Irvine, Yamaguchi University Hospital, First Affiliated Hospital, Sun Yat-Sen University, Medical University of South Carolina

Conditions

Acute Kidney Tubular NecrosisChronic PancreatitisIschemic StrokeKidney TransplantationLiver RegenerationMesenchymal Stem Cells

Phase 1

Safety of Escalating Doses of Intravenous Bone Marrow-Derived Mesenchymal Stem Cells in Patients With a New Ischemic Stroke

WithdrawnNCT01849887

University of California, IrvineIschemic Stroke

Start: 2016-01-31End: 2016-01-31Updated: 2016-01-22

Safety Study of Liver Regeneration Therapy Using Cultured Autologous BMSCs

Yamaguchi University HospitalLiver Regeneration

Start: 2014-12-31Target: 10Updated: 2014-12-30

Effect of BM-MSCs in DCD Kidney Transplantation

First Affiliated Hospital, Sun Yat-Sen UniversityAcute Kidney Tubular Necrosis, Kidney Transplantation

Start: 2015-10-31End: 2017-10-31Target: 120Updated: 2015-09-28

Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT

Active, not recruitingNCT05095532

Medical University of South CarolinaChronic Pancreatitis, Mesenchymal Stem Cells

Start: 2021-12-01End: 2027-06-30Target: 42Updated: 2026-09-09